Caitlin Smare

sFlt‐1/PlGF ratio test for pre‐eclampsia: an economic assessment for the UK

Manu Vatish, Torsten Strunz, Martin Hund et al. · Ultrasound in Obstetrics and Gynecology · 2016 · 76 citations · Full text

Medicine, Maternal Health, Obstetrics +14

Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes

Caitlin Smare, Khalid Lakhdari, Justin Doan et al. · PharmacoEconomics · 2019 · 58 citations · Full text

Pharmacy, Biostatistics, Oncology +17

Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries

Xiaoyan Lu, Caitlin Smare, Chrispin Kambili et al. · BMC Health Services Research · 2017 · 32 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Cost-Effectiveness of Cemiplimab Versus Standard of Care in the United States for First-Line Treatment of Advanced Non-small Cell Lung Cancer With Programmed Death-Ligand 1 Expression ≥50%

Andreas Kuznik, Caitlin Smare, Chieh-I Chen et al. · Value in Health · 2021 · 32 citations

Pharmacy, Oncology, Pharmacoeconomics +17

The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK

J. Mark FitzGerald, Sofie Arnetorp, Caitlin Smare et al. · Respiratory Medicine · 2020 · 22 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +15